TMB-8 free base
Based on 1 publication(s) in Google Scholar
TMB-8 free base is a benzoate ester compound. TMB-8 free base blocks intracellular calcium (Ca) release, catecholamine secretion, and cholinergic/CCK-stimulated amylase release, while stimulating pancreatic hormone release and, under hyperthermia conditions, increasing cytosolic calcium and hyperthermic cell killing. TMB-8 free base is used in research on chemotherapy-induced painful peripheral neuropathy, human promyelocytic leukemia, and mouse breast cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 57818-92-5
- Fòrmula: C22H37NO5
- Peso molecular:395.53
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) TMB-8 free base
More
Actividad biológica
Descripciòn
In Vitro
TMB-8 free base inhibits 1 μM Carbachol (Carbamoylcholine chloride) (HY-B1208)-stimulated amylase release, producing 57% inhibition at 10 μM, without affecting basal or 0.1 μM secretin-stimulated release[4].
TMB-8 free base non-selectively inhibits parasympathetic neuromuscular transmission in guinea pig ileum and contractions induced by ACh, Nicotine, DMPP, KCl, and BaCl2, with ID50 values of 3.8 × 10-6 to 14.4 × 10-6 M, but BaCl2 antagonism is competitive[7].
TMB-8 free base directly inhibits protein kinase C activity supported by Ca2+ and phosphatidylserine in the cytosol of partially purified bovine adrenal zona glomerulosa cells in a dose-dependent manner[10].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HL-60 human promyelocytic leukemia cells
-
Concentration:10, 50, and 100 μM
-
Incubation Time:4 days
-
Result:At less than 50 μM, did not affect HL-60 cell proliferation.
At 100 μM, little cell proliferation was observed, but cell viability was always more than 85%.
In Vivo
TMB-8 (46 nmol; i.t.; single injection) free base attenuates Vincristine (HY-N0488A)-induced mechanical hypersensitivity in rats[1].
TMB-8 (46 nmol; i.t.; single injection) free base attenuates ddC (Zalcitabine) (HY-17392)-induced mechanical hyperalgesia in rats[1].
TMB-8 (116 nmol/10 µL; intradermal injection; single injection) free base attenuates ddC-induced mechanical hyperalgesia in rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 250-270 g at start)[1]
-
Dosage:46 nmol in 20 µL
-
Administration:i.t.; single injection; at 22-28 days after paclitaxel
-
Result:Reduced paclitaxel-evoked mechano-allodynia on the 4-g von Frey test and mechano-hyperalgesia on the 15-g von Frey and paw-pressure tests.
-
Animal Model:Sprague-Dawley (male, 250-270 g at start)[1]
-
Dosage:46 nmol in 20 µL
-
Administration:i.t.; single injection; at 13-19 days after vincristine
-
Result:Reduced vincristine-evoked mechano-allodynia on the 4-g von Frey test and mechano-hyperalgesia on the 15-g von Frey and paw-pressure tests.
-
Animal Model:Sprague-Dawley (male, 250-270 g at start)[1]
-
Dosage:46 nmol in 20 µL
-
Administration:i.t.; single injection; at 8 days after ddC
-
Result:Reduced ddC-evoked mechano-hyperalgesia in the paw-pressure test.
-
Animal Model:Sprague-Dawley (male, 250-270 g at start)[1]
-
Dosage:116 nmol/10 µL
-
Administration:intradermal; single injection; at 8 days after ddC
-
Result:Reduced ddC-evoked mechano-hyperalgesia in the paw-pressure test.
Chemical Information
-
No. CAS 57818-92-5
-
Peso molecular 395.53
-
Fòrmula C22H37NO5
-
SMILES
O=C(C1=CC(OC)=C(C(OC)=C1)OC)OCCCCCCCCN(CC)CC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Pureza y Documentación
Referencias
[1]. Siau C, et al. Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesthesia and analgesia. 2006 May;102(5):1485-90. [Content Brief]
[4]. Ikeda M, et al. Effect of an intracellular calcium antagonist (TMB-8) on carbamylcholine-induced amylase release from dispersed rat pancreatic acini. Life sciences. 1984 Feb 06;34(6):529-33. [Content Brief]
[5]. Yasuda H, et al. Stimulative effects of TMB-8 and trifluoperazine on pancreatic hormone release. Diabetes research and clinical practice. 1989 Apr 01;6(3):227-32. [Content Brief]
[6]. Wojewodzka M, et al. Calcium antagonist, TMB-8, prevents the induction of adaptive response by hydrogen peroxide or X-rays in human lymphocytes. International journal of radiation biology. 1994 Jul;66(1):99-109. [Content Brief]
[7]. Malagodi MH, et al. Pharmacological evaluation of a new Ca2+ antagonist, 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in smooth muscles. Eur J Pharmacol. 1974 Jun;27(1):25-33. [Content Brief]
[8]. Okazaki T, et al. Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation. Cancer research. 1986 Dec;46(12 Pt 1):6059-63. [Content Brief]
[9]. Kondo T, et al. Enhancement of cell killing and increase in cytosolic calcium concentration by combined treatments with hyperthermia and TMB-8 in mouse mammary carcinoma FM3A cells. Cell calcium. 1993 Oct;14(9):621-9. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)